Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Metabolomics | 9 | 2023 | 1484 | 1.380 |
Why?
|
Peripartum Period | 2 | 2015 | 133 | 0.940 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2015 | 500 | 0.750 |
Why?
|
Embolectomy | 1 | 2019 | 120 | 0.670 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2021 | 859 | 0.650 |
Why?
|
Proteomics | 7 | 2023 | 3638 | 0.600 |
Why?
|
Recovery of Function | 2 | 2015 | 2925 | 0.490 |
Why?
|
Cardiovascular Diseases | 6 | 2023 | 15165 | 0.480 |
Why?
|
Proteome | 6 | 2023 | 1799 | 0.450 |
Why?
|
Cardiomyopathies | 2 | 2015 | 1912 | 0.440 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2021 | 1573 | 0.410 |
Why?
|
Drug-Eluting Stents | 1 | 2017 | 753 | 0.380 |
Why?
|
Echocardiography | 2 | 2021 | 5102 | 0.360 |
Why?
|
Heart Failure | 4 | 2022 | 10900 | 0.350 |
Why?
|
Coronary Disease | 2 | 2022 | 6077 | 0.340 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2019 | 1354 | 0.330 |
Why?
|
Genome-Wide Association Study | 4 | 2023 | 12261 | 0.310 |
Why?
|
C-Reactive Protein | 1 | 2019 | 3778 | 0.300 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 2376 | 0.290 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 3068 | 0.250 |
Why?
|
Genomics | 1 | 2020 | 5720 | 0.230 |
Why?
|
Oleic Acids | 1 | 2023 | 70 | 0.220 |
Why?
|
Sickle Cell Trait | 1 | 2023 | 81 | 0.220 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 11725 | 0.210 |
Why?
|
Metabolome | 3 | 2023 | 895 | 0.200 |
Why?
|
Homoarginine | 1 | 2021 | 9 | 0.200 |
Why?
|
Orotic Acid | 1 | 2021 | 23 | 0.200 |
Why?
|
Chemokine CX3CL1 | 1 | 2021 | 58 | 0.200 |
Why?
|
Spermine | 1 | 2021 | 70 | 0.190 |
Why?
|
Uridine | 1 | 2021 | 146 | 0.190 |
Why?
|
Polyamines | 1 | 2021 | 120 | 0.190 |
Why?
|
Respiration Disorders | 1 | 2023 | 371 | 0.170 |
Why?
|
Proline | 1 | 2021 | 458 | 0.170 |
Why?
|
Coronary Artery Disease | 3 | 2023 | 6487 | 0.160 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2021 | 436 | 0.150 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2021 | 476 | 0.150 |
Why?
|
Renal Insufficiency | 1 | 2023 | 804 | 0.150 |
Why?
|
Amino Acids | 1 | 2023 | 1736 | 0.140 |
Why?
|
Glycolysis | 1 | 2021 | 827 | 0.140 |
Why?
|
Pacemaker, Artificial | 1 | 2022 | 816 | 0.140 |
Why?
|
Tandem Mass Spectrometry | 1 | 2022 | 1157 | 0.140 |
Why?
|
Blood Proteins | 1 | 2021 | 1124 | 0.140 |
Why?
|
Risk Assessment | 4 | 2023 | 23338 | 0.130 |
Why?
|
Quantitative Trait Loci | 1 | 2023 | 2019 | 0.130 |
Why?
|
Humans | 31 | 2023 | 744343 | 0.120 |
Why?
|
Sinusitis | 1 | 2023 | 923 | 0.120 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1265 | 0.110 |
Why?
|
Collagen | 1 | 2021 | 2689 | 0.100 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1637 | 0.100 |
Why?
|
Nitric Oxide | 1 | 2021 | 2132 | 0.100 |
Why?
|
Stroke Volume | 2 | 2022 | 5007 | 0.100 |
Why?
|
Longitudinal Studies | 3 | 2022 | 13989 | 0.100 |
Why?
|
Proportional Hazards Models | 2 | 2022 | 12354 | 0.090 |
Why?
|
Pyrimidines | 1 | 2021 | 2942 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6895 | 0.080 |
Why?
|
Incidence | 3 | 2022 | 20947 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9687 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3047 | 0.080 |
Why?
|
Blood Glucose | 1 | 2022 | 6256 | 0.080 |
Why?
|
Computational Biology | 1 | 2020 | 3521 | 0.080 |
Why?
|
Female | 11 | 2023 | 380194 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12788 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2021 | 3445 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5034 | 0.060 |
Why?
|
Time Factors | 2 | 2017 | 40075 | 0.060 |
Why?
|
Middle Aged | 8 | 2022 | 213383 | 0.060 |
Why?
|
Asthma | 1 | 2023 | 6011 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5751 | 0.060 |
Why?
|
Cohort Studies | 4 | 2023 | 40561 | 0.060 |
Why?
|
Risk Factors | 4 | 2023 | 72290 | 0.060 |
Why?
|
Thrombosis | 1 | 2017 | 2968 | 0.060 |
Why?
|
Young Adult | 2 | 2023 | 56430 | 0.060 |
Why?
|
Pregnancy | 2 | 2015 | 29144 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2021 | 21746 | 0.050 |
Why?
|
Aptamers, Peptide | 1 | 2022 | 28 | 0.050 |
Why?
|
Diet | 1 | 2021 | 7939 | 0.050 |
Why?
|
Adult | 7 | 2023 | 214055 | 0.050 |
Why?
|
Male | 10 | 2022 | 350118 | 0.050 |
Why?
|
Aged | 5 | 2022 | 163280 | 0.050 |
Why?
|
Phenylalanine | 1 | 2023 | 365 | 0.050 |
Why?
|
Leucine | 1 | 2023 | 561 | 0.050 |
Why?
|
Fish Products | 1 | 2021 | 29 | 0.050 |
Why?
|
Hemolysis | 1 | 2023 | 420 | 0.050 |
Why?
|
Mississippi | 1 | 2021 | 88 | 0.050 |
Why?
|
Phenotype | 3 | 2023 | 16365 | 0.050 |
Why?
|
Interleukin-13 | 1 | 2023 | 389 | 0.050 |
Why?
|
Meat Products | 1 | 2021 | 99 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 9959 | 0.050 |
Why?
|
Ischemic Preconditioning | 1 | 2021 | 92 | 0.050 |
Why?
|
Cystatin C | 1 | 2021 | 250 | 0.040 |
Why?
|
Plasma | 1 | 2023 | 575 | 0.040 |
Why?
|
Carnitine | 1 | 2021 | 246 | 0.040 |
Why?
|
Mitochondria, Heart | 1 | 2021 | 247 | 0.040 |
Why?
|
Interleukin-10 | 1 | 2023 | 1200 | 0.040 |
Why?
|
Immunity | 1 | 2023 | 1012 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 783 | 0.040 |
Why?
|
Adaptation, Physiological | 1 | 2023 | 1312 | 0.030 |
Why?
|
Exercise | 2 | 2023 | 5615 | 0.030 |
Why?
|
Lactic Acid | 1 | 2021 | 1133 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 63114 | 0.030 |
Why?
|
Vegetables | 1 | 2021 | 1182 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1224 | 0.030 |
Why?
|
Fatty Acids | 1 | 2023 | 1809 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2021 | 1869 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2460 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2023 | 15519 | 0.030 |
Why?
|
Inflammation | 2 | 2023 | 10638 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2014 | 11727 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 21827 | 0.030 |
Why?
|
Internet | 1 | 2023 | 3064 | 0.020 |
Why?
|
Mice | 3 | 2023 | 81183 | 0.020 |
Why?
|
Life Style | 1 | 2021 | 3835 | 0.020 |
Why?
|
Phosphorylation | 1 | 2021 | 8436 | 0.020 |
Why?
|
Health Behavior | 1 | 2021 | 2636 | 0.020 |
Why?
|
Oxygen | 1 | 2021 | 4189 | 0.020 |
Why?
|
Signal Transduction | 2 | 2023 | 23403 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4397 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2021 | 5097 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4599 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9146 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 7729 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4931 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10397 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13284 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2015 | 77449 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 8987 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2014 | 1928 | 0.020 |
Why?
|
Animals | 3 | 2023 | 168757 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 19229 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19905 | 0.020 |
Why?
|
United States | 2 | 2023 | 69872 | 0.020 |
Why?
|
Rats | 1 | 2021 | 24260 | 0.020 |
Why?
|
Prognosis | 1 | 2023 | 29063 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12745 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25043 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 53288 | 0.010 |
Why?
|
Registries | 1 | 2014 | 8089 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 29786 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2014 | 57776 | 0.010 |
Why?
|
Concepts
(139)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_